Direct supply line integration supporting municipal clinics, research clusters, and cold-chain distribution terminals at Busan Port.
Jiangxi Serum Pharma Industries Co., Ltd. serves as a leading supplier of pharmaceutical active ingredients, biological reagents, and nutritional products. Over the past decade, our global operations have connected high-standard manufacturing hubs with advanced regulatory markets, including the evolving biotech ecosystems in South Korea's primary maritime gateway, Busan.
We specialized in maintaining absolute cold-chain compliance and document authentication (including MFDS, WHO-PQ, and US FDA DMF standards) to ensure every consignment delivered to Busan Port meets rigorous quality benchmarks.
South Korea’s biological and pharmaceutical sector has experienced double-digit compound annual growth, shifting its focal points from domestic production to advanced global collaborations. While Incheon and Osong have traditionally captured headlines, Busan has rapidly emerged as a critical clinical research hub. Driven by municipal projects such as Centum City and the Eco Delta City Biotech cluster, Busan is integrating advanced clinical trials, diagnostic development, and raw-material processing pipelines.
The strategic value of Busan lies in its world-class port infrastructure. The Busan New Port possesses sophisticated temperature-controlled warehouses, providing the vital cold-chain infrastructure required for live-attenuated vaccines, therapeutic proteins, and hyper-sensitive biological products. By utilizing maritime and air-freight networks linking Gimhae International Airport, our delivery channels secure rapid turnaround times, maintaining strict compliance with local regulatory protocols.
Procuring biological agents requires mitigating risks associated with structural degradation, active assay loss, and regulatory bottlenecks. Key challenges include:
How we address next-generation formulation and delivery requirements for advanced therapies.
Optimizing multi-component chemical blends and excipient combinations under sterile environments to minimize dissolution steps for bio-manufacturers in Busan.
Improving the physical properties of active pharmaceutical ingredients (APIs), enhancing bioavailability, mechanical stability, and rate of absorption.
Utilizing high-yield microbial and cell-culture technologies to scale up complex recombinant proteins, amino acids, and therapeutic derivatives.
To distribute biological products and vaccines within Busan, strict protocols governed by the Korea Ministry of Food and Drug Safety (MFDS) must be observed. Our distribution process integrates modern validation standards:
1. Live Temperature Tracking: Every shipment bound for Busan is equipped with calibrated USB and cellular-based data loggers (such as TempTale systems), recording continuous ambient readings. This ensures clear validation records at the port of entry.
2. Prequalified Cold Chain Packaging: We utilize advanced Vacuum Insulated Panels (VIPs) and Phase Change Materials (PCMs) that guarantee the maintenance of target temperatures (e.g., +2°C to +8°C or -20°C) for up to 120 hours of transport duration, compensating for customs processing time.
3. Comprehensive DMF & GMP Attestation: We supply full dossiers compiled in the Common Technical Document (CTD) format, facilitating immediate verification by regulatory assessors in South Korea.
A comprehensive inventory of raw materials, functional nutritional additives, and medical device systems engineered for global supply standards.
Direct answers regarding logistics, regulatory approvals, and supply capabilities for biological goods shipped to Busan.
Consult with our regulatory and logistics managers. Receive customized quotes, validate technical specifications, and lock down secure supply lines for your clinical or manufacturing enterprise.
Send Inquiry Now
